News | Press Releases

---

November 1, 2007

CVCTA EDUCATION TO OFFER LIVE CASE TRAINING FOR LEVEL I PARTICIPANTS

Course to Use Toshiba’s Aquilion 64 to Provide Physicians with Unique Training

TUSTIN, CA — November 1, 2007 — Strengthening its position as a leader in medical education and improved patient care, Toshiba America Medical Systems, Inc. today announced that its partner, CVCTA Education, will provide access to live case training for ACCF/AHA Level 1 cardiac competency requirements. Typically, live cases are only shown during level II training. CVCTA will use Toshiba’s Aquilion® 64-slice CT to provide physicians with this advanced training.

“CVCTA Education continues to raise the bar for physician training. Providing access to live case reviews for level I training courses is an important step in providing advanced training to physicians,” said Doug Ryan, senior director, CT Business Unit, Toshiba America Medical Systems, Inc. “The opportunity to partner with CVCTA on this initiative is another step toward continuing to improve delivery of care to patients across the country through advanced physician education.”

CVCTA Education, a leading provider of top-tier medical educational programs, has received industry validation of its courses. Recently CVCTA received the most number of positive reviews for its CTA courses in an online physician student review conducted by the Society of Cardiovascular Computed Tomography (SCCT). More than 161 physician respondents, the largest segment in the entire survey, submitted positive reviews regarding CVCTA Education. Of CVCTA’s responses, 94.5% gave the course a “five,” the top ranking on a scale of one-to-five. In addition, physicians were asked to provide written feedback on the course.

CVCTA Education is able to meet physicians’ needs and obtain these types of reviews by continuing to provide innovative medical education solutions. For example, the company recently announced its offering of a Peripheral Vascular CTA (PV-CTA) training course – the first of its kind to exceed the newly published ACCF/AHA Level 2 requirements in the ACCF/AHA Clinical Competence Statement on peripheral vascular Imaging with Computed Tomography and Magnetic Resonance.

Peripheral Vascular Disease (PVD) refers to diseases of the blood vessels outside the heart and brain where there is a narrowing of vessels carrying blood to the legs, arms, stomach and/or kidneys. The most common type of PVD is Peripheral Arterial Disease (PAD) in which arteries leading to these same regions develop blockages that restrict blood circulation. PVD is common in patients predisposed to vascular diseases, such as those suffering from diabetes. According to an article in Cardiovascular Imaging, an estimated 20-million people have PVD, with three to four million people going misdiagnosed or untreated.

“At CVCTA Education, we are committed to continually improving patient care by offering state-of-the-art education to the medical community,” said Dr. Tony DeFrance, medical director of CVCTA Education. “Providing physicians with early access to training with live cases gives them the real-world experience necessary to prepare them for what they will face in their practices.”

Additional information on the Toshiba’s PV-CTA course offered at CVCTA can be found atwww.medical.toshiba.com or www.cvcta.com.

About CVCTA
CVCTA Education is a leader in the design and delivery of innovative medical educational programs. It has centers in San Francisco, New York and Houston to deliver its courses to the medical community. In addition to the new Peripheral Vascular CTA offering, CVCTA trains physicians in performing, post-processing and interpreting Cardiac CT angiograms. More information about CVCTA Education can be found at www.cvcta.com.

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 191,000 employees worldwide and annual sales of $60 billion. For more information, visit www.medical.toshiba.com.